Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Below is Validea's guru fundamental report for TWIST BIOSCIENCE CORP (TWST). Of the 22 guru strategies we follow, TWST rates highest using our P/B Growth Investor model based on the published ...

A downtrend has been apparent in Twist Bioscience (TWST) lately. While the stock has lost 9.9% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its ...

Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $52.00. The company’s shares closed last Friday at $52.37.